Fortetropin supplementation prevents the rise in circulating myostatin but not disuse-induced muscle atrophy in young men with limb immobilization: A randomized controlled trial
Fig 3
CSA of Type I (A) and Type II fiber (C) of the immobilized leg at each phase, and the percentage change in CSA of Type I (B) and Type II fiber (D) during each phase. Boxes represent the 25th to 75th percentile, with the central horizontal lines indicating the median. The whiskers represent the maximal and minimal values, and the cross represents the mean value. FOR-SUPP, Fortetropin® supplement; PLA-SUPP, placebo supplement; CSA, cross-sectional area. * P < 0.05, significantly different from Day 1 and 14 (main effect), # P < 0.05, significantly different from run-in (main effect).